Abstract
Bone morphogenetic protein-2 (BMP-2) that can regenerate bone by recruiting osteo-progenitor cells and inducing osteogenic differentiation has been highlighted as an alternative therapy to treat bone defects. The therapeutic effect of BMP-2 depends considerably on the delivery carriers. Previous studies demonstrated that collagen and fibrin have the potential to serve as a carrier for delivery of BMP-2. The successful bone regeneration by collagen and fibrin with BMP-2 implantation has been shown in animal models. However, those studies were not focused on the effect of the carriers on the quality of the regenerated bone. In this study, we directly compared the quality of regenerated bone when BMP-2 was delivered with collagen or fibrin, both of which are shown to be excellent carrier for BMP-2. The microstructure, surface morphology, BMP-2 release profile was examined in vitro. To evaluate the quality of regenerated bone, both types of BMP-2 carriers were implanted into the dorsal subcutaneous spaces of the mice. Four and six weeks after implantation, the regenerated bone was evaluated by computed tomography, histology, and histomorphometric analysis. The bone regeneration by the collagen with BMP-2 was higher bone density than bone regenerated by the fibrin with BMP-2. The results of this study show that carrier of BMP-2 is an important factor affecting the quality of engineered bone.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
A Hoffmann, HA Weich, G Gross, et al., Perspectives in the biological function, the technical and therapeutic application of bone morphogenetic proteins, Appl Microbiol Biotechnol, 57, 294 (2001).
H Wang, OC Boerman, K Sariibrahimoglu, et al., Comparison of micro- vs. nanostructured colloidal gelatin gels for sustained delivery of osteogenic proteins: Bone morphogenetic protein-2 and alkaline phosphatase, Biomaterials, 33, 8695 (2012).
M Tadokoro, A Matsushima, N Kotobuki, et al., Bone morphogenetic protein-2 in biodegradable gelatin and β-tricalcium phosphate sponges enhances the in vivo bone-forming capability of bone marrow mesenchymal stem cells, J Tissue Eng Regen Med, 6, 253 (2012).
SD Boden, GJ Jr Martin, MA Morone, et al., Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate, Spine (Phila Pa 1976), 24, 1179 (1999).
H, Schliephake, HA, Weich, C, Dullin, et al., Mandibular bone repair by implantation of rhBMP-2 in a slow release carrier of polylactic acid—an experimental study in rats, Biomaterials, 29, 103 (2008).
AC Docherty-Skogh, K Bergman, MJ Waern, et al., Bone morphogenetic protein-2 delivered by hyaluronan-based hydrogel induces massive bone formation and healing of cranial defects in minipigs, Plast Reconstr Surg, 125, 1383 (2010).
A Kimura, T Watanabe, T Shimizu, et al., Bone repair of rabbit mandibular transsection using rhBMP-2 and atelocollagen gel, Eur J Med Res, 11, 355 (2006).
WG La, SH Kwon, TJ Lee, et al., The effect of the delivery carrier on the quality of bone formed via bone morphogenetic protein-2, Artif Organs, 36, 642 (2012).
WF McKay, SM Peckham, JM Badura, et al., A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft), Int Orthop, 31, 729 (2007).
PP Spicer, AG Mikos, Fibrin glue as a drug delivery system, J Control Release, 148, 49 (2010).
H Seeherman, JM Wozney, Delivery of bone morphogenetic proteins for orthopedic tissue regeneration, Cytokine Growth Factor Rev, 16, 329 (2005).
M Tagil, C Jeppsson, JS Wang, et al., No augmentation of morselized and impacted bone graft by OP-1 in a weightbearing model, Acta Orthop Scand, 74, 742 (2003).
TM Ritty, J Herzog, Tendon cells produce gelatinases in response to type I collagen attachment, J Orthop Res, 21, 442 (2003).
SW Kang, JS Kim, KS Park, et al., Surface modification with fibrin/hyaluronic acid hydrogel on solid-free form-based scaffolds followed by BMP-2 loading to enhance bone regeneration, Bone, 48, 298 (2011).
JP Sheehan, JM Sheehan, H Seeherman, et al., The safety and utility of recombinant human bone morphogenetic protein-2 for cranial procedures in a nonhuman primate model, J Neurosurg, 98, 125 (2003).
RA Deyo, A Ching, L Matsen, et al., Use of bone morphogenetic proteins in spinal fusion surgery for older adults with lumbar stenosis: trends, complications, repeat surgery, and charges, Spine (Phila Pa 1976), 37, 222 (2012).
PJ Harwood, PV Giannoudis, Application of bone morphogenetic proteins in orthopaedic practice: their efficacy and side effects, Expert Opin Drug Saf, 4, 75 (2005).
CM Murphy, MG Haugh, FJ O’Brien, et al., The effect of mean pore size on cell attachment, proliferation and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering, Biomaterials, 31, 461 (2010).
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this paper as corresponding authors.
Rights and permissions
About this article
Cite this article
Jung, SY., Ko, YJ., Jang, HS. et al. The effect of carrier for BMP-2 delivery on histological aspects of tissue-engineered bone. Tissue Eng Regen Med 10, 341–346 (2013). https://doi.org/10.1007/s13770-013-1102-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13770-013-1102-0